In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}- 3,3-dimethylbutanoate, commonly known as 5F-MDMB-PINACA, through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 3 July 2017.
chemistry [2] new psychoactive substances (NPS) [3] synthetic drugs [4]
Links
[1] http://www.emcdda.europa.eu/system/files/publications/5483/2017.4963_TDAS17003ENN_PDFWEB.pdf
[2] http://www.emcdda.europa.eu/keywords/chemistry_en
[3] http://www.emcdda.europa.eu/keywords/new-psychoactive-substances-nps_en
[4] http://www.emcdda.europa.eu/keywords/synthetic-drugs_en
[5] http://www.emcdda.europa.eu/publications/implementation-reports/2016
[6] http://www.emcdda.europa.eu/drug-situation/new-drugs